Workshop organized by the InternationaI Association for Biologicals

Scientific Committee

William Egan
PharmaNet
Ivana Knezevic
WHO
Keith Peden
FDA
Isabelle Pierard
GSK
Rebecca Sheets
NIAID/NIH
Carmen Jungbaeck
Paul Ehrlich Institute, Germany
John Lewis
Crucell
John Petricciani (chairman)
IABS
Jim Robertson
National Institute for Biological
Standards & Control (UK)
Kathy Zoon
NIAID/NIH

Advisors

Ian Gust
Univ. of Melbourne
Ryoko Krause
IFPMA
Tony Lubiniecki
Johnson & Johnson
David Onions
Bioreliance

Coordination : Dodet Bioscience - Lyon

Objectives

To review traditional and new technology for the detection of microbial agents;
To consider how progress in microbial agent detection can assist in ensuring the safety of starting materials and final products;
To consider how risk assessment can help to address safety issues;
To facilitate exchanges between experts from academia, industry and regulatory agencies.

Outcomes

Conclusions and recommendations will be issued at the end of the meeting and published.

Who should attend?

This event will be of interest to experts working in the field of human and veterinary biologicals, whether from the public or private sector or from regulatory agencies.

Meeting Venue

Baltimore, MD, USA
Baltimore Marriott Waterfront
700 Aliceanna Street Baltimore, MD, USA
www.marriott.com/hotels/travel/bwiwf-baltimore-marriott-waterfront

Workshop organized by IABS
IABS

Sponsors :
Pfizer